First in Man Trial of BI 113608

NCT01540825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608
DRUG: Placebo
DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608
DRUG: BI 113608

Sponsor

Boehringer Ingelheim